Eliciting patient preferences within the context of shared decision making has been advocated for colorectal cancer screening. Risk stratifi cation for advanced colorectal neoplasia (ACN) might facilitate more effective shared decision making when selecting an appropriate screening option. Our objective was to develop and validate a clinical index for estimating the probability of ACN at screening colonoscopy.
INTRODUCTION
Colorectal cancer (CRC) remains the third most commonly diagnosed cancer among men and women and the second overall leading cause of cancer-related death in the United States ( 1 ) . Sufficient evidence has accumulated to suggest that screening is the most effective strategy for reducing the public health burden of this deadly disease and is now widely recommended by most authoritative groups (2) (3) (4) (5) . Each of these groups endorses a menu-based approach for averagerisk patients 50 years of age that includes some combination of colonoscopy, fecal occult blood testing, flexible sigmoidoscopy, double contrast barium enema, computed tomography colonography ("virtual colonoscopy"), or stool DNA testing.
Although screening rates have steadily increased in recent years, approximately one-third of age-eligible Americans remain unscreened ( 6 ) .
Eliciting patient preferences within the context of shared decision making (SDM) has been endorsed as an appropriate and potentially eff ective strategy for increasing CRC screening rates (2) (3) (4) (5) . CRC screening is ideally suited for this approach given the availability of multiple options with distinct advantages and disadvantages, the lack of consensus regarding an optimal costeff ective strategy, and limited eff ectiveness of the more traditional paternalistic approach where primary care providers assume full responsibility for the decision-making process. Nevertheless, existing data suggest that many providers are reluctant to comply with patient preferences ( 7, 8 ) . A reliable risk index for estimating individual probability of advanced colorectal neoplasia (ACN), the target lesion for CRC screening ( 9 ) , would provide clinicians with objective decisional support when considering patient preferences and thereby potentially enhance the eff ectiveness of SDM. Although a number of prediction models have been proposed for ACN, the majority were developed and validated in select patient populations and/or included individuals at increased risk of disease because of a family history ( 10 ) . Hence, the principal objective of this study was to develop and validate a simple risk index for ACN based on readily available clinical data that accurately stratifi es a diverse average-risk patient population into low-and intermediate/high-risk categories for ACN.
METHODS

Study design
We conducted a cross-sectional study of consecutive asymptomatic, mostly English-speaking, average-risk patients presenting to the endoscopy unit at Boston Medical Center (BMC) and Tuft s Medical between 22 March 2005 and 31 January 2012. Potential study participants were identifi ed from the appointment logs and assessed for eligibility by one of the study coordinators in the endoscopy unit just before their scheduled procedure. Th e study protocol was approved by the Boston University Medical Campus and Tuft s Medical Center Institutional Review Boards.
Setting and participants
BMC is a private, community-based, academic medical center and the largest safety net hospital in New England. Approximately 70% of BMC patients are from low-income, minority groups (35% black, 19% Hispanic, 4% Asian, and 11% other) and rely on government payors for their coverage. Tuft s Medical Center is also an urban private, academic medical center that cares for a diverse patient population (70% white, 10% black, 10% Asian, and 9% Hispanic). Tuft s was added as a second study site in September 2009 to bolster recruitment and increase the representation of Asian patients in the study population. More than 95% of patients from both sites have medical insurance as a result of the Massachusetts Health Reform Law.
Patients were deemed eligible for this analysis if they were 50 to 79 years of age and due for CRC screening in accordance with current guidelines. Patients with indications other than screening, such as the presence of lower gastrointestinal symptoms, iron deficiency anemia, positive fecal occult blood testing or surveillance because of a personal history of colorectal neoplasia, or chronic infl ammatory bowel disease, were ineligible. Patients undergoing screening because of a family history of CRC or colorectal polyps aff ecting a fi rst-degree relative before age 60 years were also ineligible, on grounds that most authoritative groups endorse colonoscopy as their preferred screening strategy for these high-risk groups rather than an option-based approach driven by patient preferences ( 2 ).
Survey methodology
Th e risk assessment questionnaire was self-administered to consenting patients with adequate literacy skills using a scannable, paper-based data collection form devoid of patient identifi ers. A trained interviewer technique was used for patients with low literacy skills. Th e survey took ~5 min to complete.
Details of our survey instrument have been published ( 11 ) . Th e questionnaire initially included all 21 items of the original YourDiseaseRisk ( YDR ) index for CRC, a web-based adaptation of the validated Harvard Cancer Risk Index ( 12, 13 ) , and 15 additional items related to other putative risk factors for ACN ( Supplement 1 ). In July 2007, the questionnaire was modifi ed to refl ect changes in the YDR index ( Supplement 2 ) ( 14 ), specifi cally omitting the vegetable intake item, adding a dairy intake item, and expanding prior screening behavior to include virtual colonoscopy and stoolbased DNA testing.
Colonoscopy fi ndings and histology
All screening colonoscopies were performed by board-certifi ed attending gastroenterologists alone or assisted by a gastroenterology fellow. Endoscopic data, including the size (mm) and location of any polyps or masses, depth of scope insertion, and quality of the bowel preparation were abstracted from the computerized colonoscopy reports. All retrieved polypoid lesions or biopsy specimens were reviewed initially by board-certifi ed pathologists and classifi ed according to World Health Organization histologic criteria ( 15 ) ; each also underwent a second review by a gastrointestinal pathologist with expertise in colorectal neoplasia. Th e gastrointestinal pathologist re-reviewed any variances in classification to establish the fi nal determination. An advanced colorectal neoplasm was defi ned as a tubular adenoma ≥10 mm in size, an adenoma of any size with villous features or high-grade dysplasia, a dysplastic serrated lesion of any size, or invasive cancer ( 16, 17 ) . Patients with multiple polyps submitted individually or collectively in a single specimen container were classifi ed on the basis of their most advanced histology.
Outcome
Th e primary outcome was prevalence of ACN, defi ned as the proportion of evaluable patients with ACN. Patients with incomplete examinations because of poor bowel preparation or failure to reach the cecum for reasons other than a poor bowel preparation or obstructing neoplasm were excluded from analysis if they did not undergo a complete examination within 1 year. Patients with unretrieved polyp specimens were also excluded.
Statistical analyses
All statistical analyses were carried out using SAS, version 9.4, soft ware (SAS Institute, Cary, NC).
Sample size and power estimates
Power considerations focused on identifying independent dichotomous predictors in a multivariable logistic regression model for ACN. Assuming an overall prevalence of ACN of 4.6% ( 18 ) ( 19 ) . Based on a revised estimate of the overall prevalence of ACN of 5.5%, which was less than the fi nal prevalence of 5.7%, it was determined that a sample of 2,952 would provide similar power.
Model development
Although data for primary risk factors were missing on only 5.6% of the observations for the primary modeling variables, this proportion was similar to the observed event rate for ACN. Th us, the expectation-maximization algorithm was used to obtain estimates of the variance-covariance matrix and model coeffi cients for logistic regression models predicting ACN ( 20 ) . Estimation and testing of model coeffi cients was carried out across fi ve imputed data sets, each containing substituted values for missing data that refl ected estimates derived from other observations in the original data set. Th e variance estimates for testing and confi dence intervals (CIs) accounted for the variability between values on the imputed data sets ( 21 ) . Imputed values were used directly in the model development without any rounding for binary variables.
Simple associations of patient risk factors with the presence of ACN were tested using logistic regression models on the imputed data. Associations were summarized by the odds ratio for ACN and associated 95% confi dence intervals (95% CI). Candidate predictors with P values <0.20 in the univariable analyses were included into a multivariable logistic regression. Backward selection was used to remove variables with insignifi cant ( P ≥0.05) contributions to multivariable model fi t. Based on published data ( 11, 22 ) , an interaction between race/ethnicity and sex was tested. Internal validity for selected variables was summarized by the percentage of times that each variable was statistically signifi cant ( P <0.05) and would have been scored (with an odds ratio >1.25) on 1,000 bootstrap samples of 3,453 patients per sample with replacement from the original imputed study data set.
Th e net reclassifi cation improvement (NRI) was used to summarize the improvement in classifi cation when a predictor identifi ed in the multivariable logistic model was added to the model ( 23, 24 ) . Patients were classifi ed as predicted to have ACN if their predicted probability from the model was >5.7%, the mean overall prevalence of ACN in the data set. Th e NRI is estimated by calculating the net percentage of patients with ACN, which were reclassifi ed from low risk to intermediate/high risk added to the percent of subjects without ACN, which were reclassifi ed from intermediate/ high risk to low risk when the predictor was added to the regression model. Th us, higher NRI values are associated with greater improvement in appropriate classifi cation of subjects. Th e calculated NRI value should not be interpreted as an estimate of proportional risk for the outcome of interest.
Model performance
Model performance was assessed by the C-statistic for discrimination by calculating the area under the receiver-operating characteristic curve and by plots of model calibration. Confidence limits for the area under the receiver-operating characteristic curve were generated from the 2.5 and 97.5% percentiles from prediction on regression models generated on the 1,000 imputed bootstrap data sets to provide estimates of precision and internal validity. Model calibration comparing observed and predicted ACN rates across deciles of predicted risk were checked on each of the fi ve imputed data sets and tested for statistical signifi cance using the Hosmer and Lemeshow goodnessof-fi t test.
ACN scoring algorithm
Points were assigned to each predictor based on the number of 0.5 levels above the referent odds of 1.0, rounded to the nearest level. Individual risk estimates were based on the sum of weighted scores for each variable. To create an easy to use two-tier risk stratifi cation index, individual cumulative scores were collapsed into low-and intermediate/high-risk categories based on the corresponding observed rates of ACN. Adjusted 95% CIs for the rate of ACN were generated for each risk category using the bootstrap methods described above. Th e actual cut-point was optimized to insure that: (1) the prevalence of ACN in the low-risk group was suffi ciently low (range, 2-3%; Schroy et al. ( 25 ) ) to infl uence provider decision making, and (2) the proportion of patients categorized as low risk was large enough to be clinically relevant, recognizing that ~30-60% of patients may prefer tests other than colonoscopy ( 8, 26, 27 ) .
RESULTS
Patient characteristics
Figure 1 depicts the number of prescreen eligible patients who declined to participate, deemed ineligible based on inclusion/ exclusion criteria, or excluded because of inadequate bowel preparation, incomplete examination for reasons other than an inadequate bowel preparation, or failed polyp retrieval for each sample. Table 1 presents the characteristics of the 3,543 participants included in the study, with 98.4% enrolled at BMC, 74.7% aged 50-59 years, and 50.5% black with an equal percentage of males and females. Th e mean overall rate of ACN was 5.7% (95% CI, 5.0-6.6%).
Model composition
Univariable associations between potential risk factors and ACN are presented in Table 1 . Age as a continuous variable, height, smoking behavior, alcohol intake, non-steroidal anti-infl ammatory drug use, red meat consumption, and family history of CRC aff ecting a fi rst-degree relative at age ≥60 years had P values <0.20 and were included as covariates in the multivariable logistic regression models. Results from a logistic regression model with terms for sex and race/ethnicity supported the inclusion of an interaction term for race/ethnicity by sex ( P <0.001). Multivariable model coeffi cients, odds ratio estimates, and 95% CIs for the imputed data sets are given in Table 2 . Aft er adjustment, only age, a combined sex/race/ethnicity variable, smoking, alcohol intake,
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and height remained signifi cant ( P <0.05) and were included in the fi nal model. Each of the selected variables had positive NRIs and was signifi cant (odds ratio >1.25) in >50% of bootstrap samples with repeated sampling ( Table 2 ). Conversely, non-steroidal anti-infl ammatory drug use, meat consumption, and family history were excluded as they were not statistically signifi cant aft er adjustment for the other covariates in the model, had low or negative NRIs, and were statistically signifi cant in <50% of samples with repeated sampling.
Model performance and validation
Th e fi nal model demonstrated moderate to good discrimination (C-statistic, 0.69; 95% CI, 0.66-0.72) on the imputed data set.
Performance varied by race and ethnicity with the strongest discrimination for whites (C=0.73; 95% CI, 0.68-0.77) followed by Hispanics (C=0.66; 95% CI, 0.53-0.78), blacks (C=0.63; 95% CI, 0.57-0.69), and others (C=0.59; 95% CI, 0.44-0.74), but these differences did not achieve signifi cance because of overlapping confi dence internals. Performance also varied by sex with stronger discrimination for males (C=0.69; 95% CI, 0.65-0.73) compared with females (C=0.66; 95% CI, 0.60-0.71), but these diff erences were again nonsignifi cant. As shown in Figure 2 , there were no systematic biases in agreement with observed and predicted rates of ACN across deciles of predicted risk (Hosmer-Lemeshow test, P =0.73-0.92). Th e NRI, refl ecting the improvement in appropriately identifying individuals with ACN as intermediate/high or low risk, was strongest for the smoking variable for which there was a net improvement of 8.4% in classifi cation when compared with a model lacking this variable ( Table 2 ) . Th e net improvement in classifi cation for inclusion of the other variables was 2.2% for the race/ethnicity by sex interaction, 1.7% for both age and alcohol, and 1.5% for height.
ACN scoring algorithm
Each of the fi ve predictors were assigned a point value based on the number of 0.5 levels above the referent odds of 1.0, rounded to the nearest level ( Table 3 ). For the combined sex/race/ethnicity variable, white males were assigned a score of 2 based on the observed odds ratio of 1.79 ( P =0.022); scores of 0 were assigned to each of the other groups, except black males, as none of the adjusted odds ratios were signifi cant. Black males were assigned a one-point score based on published data demonstrating significantly higher rates of ACN compared with non-Hispanic white women ( 11, 22, 28, 29 ) . Summing the points yielded total risk scores that ranged from 1 to 11, with the higher scores indicating greater predicted risk for ACN. Mean ACN rates for each of these scoring categories are shown in Table 4 . Scores were collapsed into two categories, scores 1 to 2 or >3, to identify potential low-risk and intermediate/high-risk individuals, respectively. Th e mean ACN rate in the low-risk group was 3.2% (95% CI, 2.6-3.9%) and 8.6% (95% CI, 7.4-9.7%) for the intermediate/high-risk group. Th e proportion of patients with ACN identifi ed as intermediate/high risk was 70.1% (95% CI, 63.6-76.3) and the proportion without ACN with estimated low risk was 54.4% (95% CI, 52.7-56.0).
DISCUSSION
Risk stratifi cation for ACN provides a rational strategy for facilitating shared decision making when selecting an appropriate CRC strategy and for improving the cost eff ectiveness of screening colonoscopy. An essential prerequisite to this approach is the availability of an accurate risk assessment tool. Our study fi nds that a simple, user-friendly index, hereaft er referred to as the ACN Index (ACNI), comprised of fi ve predictors of risk (age, a combined sex/race/ethnicity variable, smoking, alcohol consumption, and height) accurately stratifi es a diverse population of averagerisk patients for CRC into low-and intermediate/high-risk groups for the presence of ACN at screening colonoscopy. One measure of the likely validity of a risk index relates to the evidence base for the key predictors. Each of the ACNI predictors is an established risk factor for both advanced adenomas and invasive cancer. Positive associations with increasing age ( 30 ), male sex ( 31 ), alcohol use ( 32, 33 ) , long-term exposure to cigarette smoke ( 34 ) , and tallness ( 35, 36 ) have been affi rmed by numerous observational studies. Data regarding associations between race/ethnicity and ACN, however, have been more confl icting and appear to vary on the basis of age and sex ( 22, 28, 29, 37, 38 ) . Aft er controlling for other determinants of risk and the interaction between sex and race/ethnicity, we observed signifi cantly higher rates of ACN among non-Hispanic white males than other racial groups, including blacks, as reported previously ( 11 ) . We speculate that selection bias related to access to screening colonoscopy and failure to account for diff erential exposure to modifi able risk factors for ACN, including prior colonoscopy, might account for the much of the variance between our fi ndings and Percent of bootstrap samples a variable would be given a score or 1 or greater and be statistically signifi cant ( P <0.05). c All logistic regression models included adjustments for the variables in the fi nal model (age, the race/ethnicity by sex interaction, smoking, alcohol intake, and height). studies that fi nd similar ( 29, 37, 38 ) or higher ( 22, 28 ) rates of ACN among black males compared with white males. Population-based data demonstrating that non-Hispanic white males also had the highest incidence rates of CRC in the 1980s before the surge in screening lends credence to our fi ndings ( 39 ) . Although absolute rates of disease varied among males and females for the other racial and ethnic groups studied, no signifi cant diff erence were observed, presumably because of the relatively low prevalence of ACN and small sample size. Even if signifi cant diff erences were observed in a larger study, existing prevalence data would suggest that the magnitude of diff erence is unlikely to warrant a change in the weighted score. Th e sole exception would be black males for whom there is compelling evidence of increased risk compared with non-Hispanic white women to warrant our assignment of 1 point in our scoring system ( 11, 22, 28, 29 ) . Th e exclusion of many other candidate predictors from our model (e.g., body mass index) in no way refutes their importance as risk factors for ACN, as our study has insuffi cient power for validating the signifi cance of factors with low exposure rates or low attributable risk in the general population.
Besides including credible predictors, an index should meet performance standards related to discrimination (ability to distinguish low-from high-risk individuals), calibration (agreement between observed and predicted outcomes), and internal validity. Although our index demonstrated only moderate to good discriminative ability, its performance compares favorably with the discriminative ability of other existing models for both average-( 10 ) and high-risk patients ( 40 ) . Nevertheless, extrapolation of our fi ndings suggest that as many as 30% of patients without ACN will be misclassifi ed as "intermediate/high-risk" (false positives) and that as many as 45% of patients with ACN may be misclassifi ed as "low-risk" (false negatives). Nevertheless, even poorly discriminating models may have clinical utility in situations where the clinical decision is a "toss up" as in the case of CRC screening test selection ( 41 ) , or where there is a lack of consensus regarding a single best option ( 42, 43 ) . Th e variable performance of the model as a function of sex and race/ethnicity suggests that other risk factors not included in the model may be important predictors of ACN in select patient populations. Nevertheless, the model was well calibrated and internally validated using bootstrapping methods. Although internal validation methods are more prone to overfi tting than external validation, the use of bootstrapping is more effi cient than split-sample validation and provides more stable estimates with less bias than cross-validation methods ( 44 ) .
Our index addresses many of the limitations of previously described prediction models for colorectal neoplasia. First, our index provides real-time estimates of risk for existing ACN rather than projections for the future development of CRC ( 14, 45, 46 ) , thus enhancing its potential utility for facilitating eff ective shared decision-making for individual patients. Second, our index targets both advanced adenomas and cancers rather than just cancers. Although most studies have observed few diff erences between risk factors for non-advanced adenomas, advanced adenomas, and invasive cancers, we have previously shown that the YDR index lacks accuracy for discriminating those at low vs. intermediate or high risk for ACN at screening colonoscopy ( 47 ) . Th ird, unlike the 
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erences for tests other than colonoscopy for individuals at low risk; alternatively, patients who prefer tests other than colonoscopy may be more receptive to colonoscopy if informed that they are at increased risk. We have previously reported that most primary care providers were willing to use such a tool, assuming that it minimized disruptions to workfl ow, was easy to use, and required minimal time to complete ( 25 ) . Th e ACNI's simple scoring algorithm using readily available clinical information satisfi es these prerequisites, especially if adapted into an electronic format and automated within electronic health records.
In conclusion, we have developed and internally validated a new risk prediction index for ACN that stratifi es average-risk patients into low-and high-risk categories for ACN at screening colonoscopy. Although performance varied on the basis of sex and race/ ethnicity, we believe that the index has adequate discriminative ability to facilitate shared decision making related to screening test selection and individualized risk assessment, particularly in situations where patient and provider preferences diff er. Future studies are needed to externally validate the performance of the index among diverse populations and to determine the extent to which providers are willing to incorporate such a tool into clinical practice.
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Our study has several unique strengths. Th e racial, ethnic, and socioeconomic diversity of our study population satisfi es a National Cancer Institute recommendation and enhances the generalizability of our fi ndings ( 54 ) . Our recruitment strategy enabled us to maximize our response rate and minimize selection bias. Our study protocol minimized recall bias, as patients completed the questionnaire before undergoing their screening colonoscopy and thus were unaware of the fi ndings of their examination. Last, we restricted our analyses to patients with complete examinations with adequate preparations and complete retrieval of all polyp specimens to minimize misclassifi cation.
Our study also had several important limitations. First, we failed to validate the performance on our index on an external data set, so concerns about overfi tting and generalizability are warranted. Second, although patients were recruited consecutively and enrollment was high, the use of a convenience sample also raises concern about potential selection bias. Th ird, despite the large number of candidate predictors examined, we failed to consider other putative anthropomorphic (e.g., hip-to-waist circumference) or biological (e.g., C-reactive protein levels) determinants of risk. Although the inclusion of such predictors might have enhanced the discriminative ability of our index, we speculated that logistical challenges related to real-time measurement during the clinician-patient encounter might deter adoption into clinical practice. Similarly, we also opted to exclude potential socioeconomic determinants of risk because the content of our questionnaire and setting captured the likely mediators of the increased risk of CRC among disadvantaged populations, namely adverse health behaviors (e.g., obesity, smoking, unhealthy diet, and physical activity) and poor access to screening ( 55, 56 ) . Fourth, we relied on the subjective judgment of multiple endoscopists to provide data about polyp size, thereby raising the possibility of misclassifi cation for ACN defi ned by size alone ( 57 ) . Fift h, our reliance on self-reported data raises the possibility of social response bias, particularly with respect to body mass index, alcohol consumption, and smoking history. Last, the model was derived based on a cross-sectional analysis of patients willing to undergo screening colonoscopy and hence its validity among patients unwilling or unable to undergo screening colonoscopy is unknown.
Despite the limitations, our index provides a clinically useful tool for facilitating shared decision making related to CRC screening, particularly in situations in which provider and patient preferences diff er. Conceptually, providers who prefer colonoscopy may be more willing to comply with patient pref-ment, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; nor decision to submit the manuscript for publication. Potential competing interests: None.
Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Eliciting patient preferences for a particular CRC screening option might increase adherence.
✓ Patient and provider preferences for CRC screening tests often vary.
✓ Risk stratifi cation for the presence of ACN provides a rational means of reconciling these differences.
WHAT IS NEW HERE
✓ A simple fi ve-item risk index based on readily available clinical data accurately stratifi es average-risk patients into low-and high-risk categories for ACN at screening colonoscopy.
✓ Uptake of this novel risk index into clinical practice could facilitate more effective shared decision making related to CRC screening.
